Menopause: an important milestone in women's health

Ang SB, How CH
Correspondence: Dr Ang Seng Bin, angsengbin@gmail.com

ABSTRACT
Menopause, a natural process in a woman’s life, is defined as the cessation of menstrual period for 12 consecutive months. In Singapore, the average age of natural menopause is 49 years of age. We discuss the challenges faced by menopausal women and provide an example of a holistic approach to the management of women during this important stage of their lives.

Keywords: hormone replacement therapy, menopause, women health
Singapore Med J 2013; 54(2): 60–63; http://dx.doi.org/10.11622/smedj.2013025

http://smj.org.sg/sites/default/files/5402/5402practice1.pdf

REFERENCES

1. Loh FH, Khin LW, Saw SM, Lee JJ, Gu K. The age of menopause and the menopause transition in a multiracial population: a nation-wide Singapore study. Maturitas 2005; 52:169-80. http://dx.doi.org/10.1016/j.maturitas.2004.11.004

2. Chim H, Tan BH, Ang CC, et al. The prevalence of menopausal symptoms in a community in Singapore. Maturitas 2002; 41:275-82. http://dx.doi.org/10.1016/S0378-5122(01)00299-7

3. Department of Statistics Singapore. Population Trends 2012 [online]. Available at: www.singstat.gov.sg/pubn/popn/population2012b.pdf. Accessed February 5, 2013.

4. Haines CJ, Xing SM, Park KH, Holinka CF, Ausmanas MK. Prevalence of menopausal symptoms in different ethnic groups of Asian women and responsiveness to therapy with three doses of conjugated estrogens/ medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study. Maturitas 2005; 52:264-76. http://dx.doi.org/10.1016/j.maturitas.2005.03.012

5. Huang KE, Xu L, I NN, Jaisamrarn U. The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function. Maturitas 2010; 65:276-83. http://dx.doi.org/10.1016/j.maturitas.2009.11.015

6. Izikson L, English JC 3rd, Zirwas MJ. The flushing patient: differential diagnosis, workup, and treatment. J Am Acad Dermatol 2006; 55:193-208. Review. http://dx.doi.org/10.1016/j.jaad.2005.07.057

7. Guidance for Industry – Estrogen and Estrogen/Progestin Drug Products to Treat Vasomotor Symptoms and Vulvar and Vaginal Atrophy Symptoms —Recommendations for Clinical Evaluation [online]. Available at: www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM135338.pdf. Accessed January 28, 2013.

8. Innes KE, Selfe TK, Vishnu A. Mind-body therapies for menopausal symptoms: a systematic review. Maturitas 2010; 66:135-49. http://dx.doi.org/10.1016/j.maturitas.2010.01.016

9. Santen RJ, Allred DC, Ardoin SP, et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab 2010; 95(7 Suppl 1):s1-s66. http://dx.doi.org/10.1210/jc.2009-2509

10.American College of Obstetricians and Gynecologists Committee on Gynecologic Practice; American Society for Reproductive Medicine Practice Committee. Compounded bioidentical menopausal hormone therapy. Fertil Steril 2012; 98:308-12. http://dx.doi.org/10.1016/j.fertnstert.2012.06.002

11. Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database Syst Rev 2012; 9:CD007244.

12. Rada G, Capurro D, Pantoja T, et al. Non-hormonal interventions for hot flushes in women with a history of breast cancer. Cochrane Database Syst Rev 2010; 9:CD004923.

13. Unfer V, Casini ML, Costabile L, et al. Endometrial effects of long term treatment with phytoestrogens: a randomized, double-blind, placebocontrolled study. Fertil Steril 2004; 82:145-8. http://dx.doi.org/10.1016/j.fertnstert.2003.11.041

14. Palacios S, Pornel B, Vázquez F, et al. Long-term endometrial and breast safety of a specific, standardized soy extract. Climacteric 2010; 13:368-75. http://dx.doi.org/10.3109/13697131003660585

15. Young T, Rabago D, Zgierska A, Austin D, Laurel F. Objective and subjective sleep quality in premenopausal, perimenopausal and postmenopausal women in the Wisconsin Sleep Cohort Study. Sleep 2003; 26:667-72.

16. Pien GW, Sammel MD, Freeman EW, Lin H, DeBlasis TL. Predictors of sleep quality in women in the menopausal transition. Sleep 2008; 31:991-9.

17. Blümel JE, Cano A, Mezones-Holguín E, et al. A multinational study of sleep disorders during female mid-life. Maturitas 2012; 72:359-66. http://dx.doi.org/10.1016/j.maturitas.2012.05.011

18. Lampio L, Saaresranta T, Polo O, Polo-Kantola P. Subjective sleep in premenopausal and postmenopausal women during workdays and leisure days: a sleep diary study. Menopause 2013 Jan 14 [Epub ahead of print]. http://dx.doi.org/10.1097/gme.0b013e31827ae954

19. Goldstein I, Alexander JL. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women. J Sex Med 2005; 2 Suppl 3:154-65. http://dx.doi.org/10.1111/j.1743-6109.2005.00131.x

20. Ministry of Health Singapore. Clinical Practice Guidelines for Health Screening. July 2003.

21. Ministry of Health Singapore. Clinical Guidelines for Cancer Screening. February 2010.